GB is a 4 month old male currently living with his aunt. His mother is deceased and nothing is known about the mother's health or the birth history. Over the last 4 weeks, GB developed worsening watery non-bloody diarrhea and felt warm to his caregivers. Over the last week his oral intake decreased significantly; he is being fed formula and phala (soft maize porridge). On examination, GB appears very wasted and is irritable. His weight is 2.8 kilograms; his length is 58 centimeters which calculates to a weight for height Z score (WHZ) of -4.0. His temperature is 34.6 C. His heart rate is 180/min. Respiratory rate is 60/min. His skin hangs loosely and he has very little muscle mass. In his oropharynx he has thick white plaques covering his tongue and his mucous membranes are dry. His lungs are clear and he has minimal retractions. His heart exam is notable for a prominent visible heart pulsations due to his thin body habitus. There are no appreciable murmurs or gallops. He has good bowel sounds, with a liver edge palpable 2 centimeters below the right costal margin and a palpable spleen tip. He also has diffuse lymphadenopathy. The infant is admitted and management is started for his malnutrition. The doctor also orders an HIV test which comes back reactive. CD is an 18 month old HIV infected female who has been on ARVs for 6 weeks admitted to a nutritional rehabilitation unit for the third time in 4 months. CD has had a fever daily for the past 2 weeks and has been coughing for 3 months per her mother's report, and seems to be worsening. CD has a documented weight loss since her discharge 8 weeks earlier of 400 grams. When queried about adherence to ARVs and co-trimoxazole, the mother reports 100% adherence and pill counts support this. On exposure history, it is revealed that the child's mother was diagnosed 4 months earlier with smear negative tuberculosis (TB) and was started on therapy. The mother has improved on therapy and gained weight. CD's 4 year old sister has also been coughing for 2 months with low To determine if CD has active TB disease, we must review her symptoms as well as obtain a chest x-ray (CXR). Even if the CXR were negative, given CD's poor immune status and consistent symptoms, she meets a clinical diagnosis of active TB infection and should be treated accordingly (see answer 5). If she were a well asymptomatic child with a negative CXR, the diagnosis would be latent TB infection and prophylaxis with 6 months of isoniazid would be indicated. 3. Chest X-ray findings in tuberculosis can be quite varied, ranging from paratracheal and hilar adenopathy to atelectasis of lobes (from airway compression from adenopathy) to a widened mediastinum to parenchymal findings. Other findings include a diffuse or miliary pattern (often described as a snow storm appearance), pleural effusions, and cardiomegaly (in the case of TB pericarditis with effusion). It is rare that children develop the cavitary disease seen in adults, but can be seen in adolescents; they are usually thin walled in appearance on CXR. Fortunately, young infants and children are not highly contagious for TB because of the absence of cavitation and weak cough.
Questions for
Chest X-ray showing bilateral perihilar lymphadenopathy, widening of mediastinum and splaying of the carina.
4. Though much is made of the highly contagious nature of sputum positive TB, it should be realized that sputum negative TB is far more prevalent and likely accounts for many more secondary infections. In one model of TB infection patterns it is estimated that smear positive individuals are 6 times more likely to transmit the infection to others. However, the ratio of smear negative to smear positive individuals in the population is estimated to be 35 to 1. 5. Standard therapy for treatment of pulmonary TB in Malawi includes the drugs Isoniazid (H), Rifampicin (R), Pyrazinamide (Z) and Ethambutol (E). For sputum positive TB, treatment is with RHZE 3 times weekly for 2 months
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followed by EH daily for 6 months. For sputum negative TB, RHZ is used for the initial phase. Sputum is often difficult to obtain from young children, but it should be attempted to try to determine sputum status as well as attempting to grow the bacteria so that it may be tested for susceptibilities if indicated. Another approach is to obtain sputum from the patient's mother or symptomatic adults who care for the child.
To recover, both TB treatment and ARVs are needed.
Treating the TB first may decrease the likelihood of immune reconstitution syndrome (see answer 6). If TB treatment is started prior to ARVs, the TB drugs should be allowed to attain steady state. Old recommendations were to wait at least 2 months before starting ARVs; however, this timetable may be able to be moved up to starting ARVs 2 to 4 weeks after TB treatment in select severely immunocompromised children in need of urgent ARV therapy. Rifampicin interacts with nevirapine, one of the three drugs given in the ARV regimen. Rifampicin increases the metabolism of nevirapine, resulting in lowered nevirapine levels. Because of this, children on TB therapy who are starting ARVs should start on full dose nevirapine and not the initial 2 week lead in of half dose nevirapine that is standardly done in patients not on TB therapy. 6.CD's course is suggestive of Immune Reconstitution Inflammatory Syndrome, abbreviated as IRIS. IRIS is seen in severely immunocompromised individuals who achieve immunological recovery be it from ARV therapy, improvement in severe malnutrition, or discontinuation of medicines that suppress the immune system. In their suppressed immunologic state, patients often have smoldering infections that have not clearly demonstrated themselves due to the absence of inflammation which would normally be caused by a healthy immune system. When the immune system recovers, it then sees these infections and attacks them exuberantly, resulting in a potentially overwhelming inflammatory state. IRIS has been described in patients who have been on ARVs for weeks to months, although it is usually seen on the earlier end of this spectrum. Other infections with which IRIS can be seen include Pneumocystis pneumonia, cryptococcal meningitis, and hepatitis. Unfortunately, in the severely suppressed patient, distinguishing between IRIS and a new serious infection is difficult; IRIS must be considered a diagnosis of exclusion. Further work to define consistent clinical criteria to define IRIS is needed.
